Pharmaceutical Analytical Services
Analytical Testing For Pharmaceutical Development and Manufacturing
Quantum Analytics Group helps pharmaceutical and biotechnology companies reduce technical and regulatory risk through scientist-led GMP analytical testing and CMC support. From early development through commercial manufacturing, we provide accurate, defensible analytical data that supports confident product, quality, and regulatory decisions.
One scientific partner for the decisions that move a product forward
Analytical needs change as a pharmaceutical program advances. Early development requires characterization and method strategy. Manufacturing requires reliable material and product testing. Release and regulatory milestones require defensible data and documentation. Commercial products require ongoing support when methods, processes or results change.
Quantum Analytics Group works directly with pharmaceutical and biotechnology teams across these stages, providing practical analytical strategies, responsive technical support and clear scientific communication - supporting development, manufacturing, release and lifecycle decisions.
Development Risk
Develop, optimize or remediate methods that are fit for the product, matrix and lifecycle stage.
Manufacturing risk
Evaluate incoming materials, batch consistency, unexpected results and process-related concerns.
Release and regulatory risk
Generate reliable analytical data and documentation for quality decisions, batch disposition and applicable regulatory expectations.
Lifecycle risk
Support method changes, process investigations, supplier changes, unexpected results and continued product-quality decisions.
ANALYTICAL DEVELOPMENT
Build analytical methods that remain useful as the program advances.
Quantum supports analytical programs where a method must be created, optimized, validated, transferred or remediated for use in development, manufacturing, release or ongoing product support.
Rather than treating method development as an isolated laboratory exercise, our scientists consider formulation complexity, expected impurities, required sensitivity, compendial context, lifecycle stage and the intended quality or regulatory use of the data.
Define The Analytical Target
Clarify analytes, product matrix, specifications, sensitivity, selectivity and the decision the method must support.
Develop Or Optimize
Select appropriate techniques and conditions, evaluate interferences and improve performance for routine use.
Demonstrate Suitability
Support qualification, verification or validation based on intended use and applicable requirements.
Transfer And Troubleshoot
Support method transfer, investigate performance gaps and remediate methods that are not working as intended.
PRODUCT-FOCUSED ANALYTICAL STRATEGIES
Support Organized Around the Material or Product Your Team Must Understand
Our scientists consider the product matrix, materials, manufacturing process, regulatory pathway and lifecycle stage before selecting the analytical approach.
APIs, Raw Materials & Excipients
Identity, purity, potency, suitability and compendial support before materials affect development or manufacturing.
Rx & OTC Drug Products
Analytical development and testing for finished dosage forms across development and commercial quality activities.
Combination Products
Analytical support for the drug, formulation, packaging interface and product-specific risks.
Medical Device Support
Advanced analytical support for device materials, unknowns and technical investigations.
ACROSS THE PHARMACEUTICAL LIFECYCLE
Analytical Support from Early Development Through Release and Lifecycle Management.
Quantum can support individual analytical activities or provide continuity as a program advances. Project scope is tailored to the product, stage, regulatory objective and quality-system requirements.
01 - Discover
Early Development
Define analytical risks, characterize materials and establish a practical testing strategy.
02 - Develop
Methods & Product Knowledge
Develop or optimize methods and build understanding of the product, matrix and impurities.
03 - Establish
Validation & Transfer
Demonstrate method suitability and support verification, validation or transfer activities.
04 - Support
Manufacturing & Scale-Up
Support raw-material, in-process, product and investigation needs as manufacturing programs advance.
05 - Release
Stability, Batch & Regulatory Milestones
Develop or optimize methods and build understanding of the product, matrix and impurities.
06 - Sustain
Commercial Lifecycle Management
Address method changes, supplier or process changes, unexpected results and post-approval analytical needs.
GMP analytical support across the CMC lifecycle.
From early stage method development through GMP testing and complex investigations, Quanum Analytics Group helps develope analytical methods and programs appropriate for the product and lifecycle stage.
Method Development & Optimization
Develop or improve methods for products, matrices and performance requirements.
Validation, Verification & Transfer
Establish and document method performance for the intended use .
Raw Materials & Excipients
Confirm Identity, purity, potency and suitability before materials affect manufacturing.
Drug Substances & Drug Products
Support characterization, specifications, release and quality decisions.
Residual Solvents
Routine and customized teting using Headspace GC-FID, Headspace GC-MS, and complementary methods..
Elemental Impurities
Risk based ICP-MS and ICP_OES techniques supporting USP<232>/<233>, ICH Q3D and Ph. Eur. 2.4.20

Stability & Release Support
Incoming material verification, batch consistency checks, production troubleshooting, and failure analysis.
Impurities, Unknowns & Contaminants
Investigation of degradation products, unexpected peaks, foreign materials, and trace contaminants.
START A CONVERSATION
What analytical decision does your team need to make?
Every analytical challenge is different. Begin with a confidential technical discussion to explore your objectives, analytical needs, and project timeline. If a more detailed review is appropriate, proprietary information can be shared under a mutually executed confidentiality agreement.
Monmouth Junction, NJ 08852
Corp & Admin Offices:
30 N Gould Street Suite 10683
Sheridan, WY 82801 USA
.png?width=100&height=104&name=Frame%204%20(1).png)
